BTA 0.00% 57.0¢ biota holdings limited

the sankyo team-up is not relenza but was loosely called relenza...

  1. 1,130 Posts.
    the sankyo team-up is not relenza but was loosely called relenza mk2; it is now identified as LANI ( long action neuramidase inhibitor) the product is now in phase 1 trial and is own 50/50 by bta/sankyo
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.